Become a Member
Dark Mode
Become a Member
Naukri Crisis
Maharashtra Election
India Fights Fraud
Uncovering Hate
Manipur Conflict
Climate Change
Members Only
WebQoof
My Report
More
Brand Studio
FIT
Gender
Opinion
Videos
Entertainment
Sports
World
Explainers
More
Podcasts
Politics
The Quint Lab
Graphic Novels
Law
Education
Members' Opinion
South Asians
NEON
Dark Mode
Become a Member
Home
Naukri Crisis
Maharashtra Election
India Fights Fraud
Uncovering Hate
About Us
T&C
Privacy Policy
BECOME A MEMBER
Created by potrace 1.16, written by Peter Selinger 2001-2019
FOLLOW US ON
About Us
Contact Us
Privacy Policy
ADVERTISEMENT
REMOVE AD
×
×
DGCI
DCGI Grants Emergency Use Approval to Corbevax Vaccine for 12–18 Age Group
DGCI Grants Conditional Market Approval for Covaxin & Covishield
ADVERTISEMENT
REMOVE AD
DCGI Grants Emergency Use Approval to Corbevax Vaccine for 12–18 Age Group
DGCI Grants Conditional Market Approval for Covaxin & Covishield
DGCI Gives Nod For Phase-3 Trials of Bharat Biotech’s Intranasal COVID Vaccine
Covaxin Approved for Children Between 2-18 Yrs By Expert Panel: How Safe is It?
